Efficacy and safety of the CRTh2 antagonist AZD1981 as add-on therapy to inhaled corticosteroids and long-acting β(2)-agonists in patients with atopic asthma

OBJECTIVES: To evaluate the efficacy and safety of AZD1981, a potent, specific antagonist of the CRTh2 receptor, as add-on therapy to inhaled corticosteroids (ICS) and long-acting β(2)-agonists (LABA), in patients with persistent asthma with an allergic component. PATIENTS AND METHODS: In this place...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Drug Des Devel Ther
Asıl Yazarlar: Bateman, Eric D, O’Brien, Christopher, Rugman, Paul, Luke, Sally, Ivanov, Stefan, Uddin, Mohib
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2018
Konular:
Clinical Trial Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5942163/
https://ncbi.nlm.nih.gov/pubmed/29765200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S147389
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller